{"entity":{"type":"insider","cik":"0001827621","url":"/insider/0001827621","json_url":"/insider/0001827621.json","name":"Werner Milton H.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":4,"first":"2021-11-19","last":"2022-08-16","span_basis":"filed_date"},"name_variants":[{"name":"Werner Milton H.","source":"filing","n_filings":4,"first_seen":"2021-11-19","last_seen":"2022-08-16"}],"transactions":[{"id":6691516,"accession":"0000899243-22-028794","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-028794","line_url":"/filing/0000899243-22-028794#line-1","is_derivative":false,"issuer_cik":"0001750149","issuer_name":"Inhibikase Therapeutics, Inc.","issuer_ticker":"IKT","issuer_name_source":null,"issuer_url":"/issuer/0001750149","owner_cik":"0001827621","owner_name":"Werner Milton H.","owner_display_name":"Werner Milton H.","owner_url":"/insider/0001827621","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","total_whole":"4,000","shares_owned_after":5335433.0,"shares_owned_after_display":"5,335,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-16","scope":"insider"},{"id":6645335,"accession":"0000899243-22-020094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-020094","line_url":"/filing/0000899243-22-020094#line-1","is_derivative":false,"issuer_cik":"0001750149","issuer_name":"Inhibikase Therapeutics, Inc.","issuer_ticker":"IKT","issuer_name_source":null,"issuer_url":"/issuer/0001750149","owner_cik":"0001827621","owner_name":"Werner Milton H.","owner_display_name":"Werner Milton H.","owner_url":"/insider/0001827621","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.976,"price_display":"0.98","price_state":"stated","total_value":4880.0,"total_display":"4,880.00","total_whole":"4,880","shares_owned_after":5330433.0,"shares_owned_after_display":"5,330,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-05-31","scope":"insider"},{"id":6803742,"accession":"0000899243-22-019229","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-019229","line_url":"/filing/0000899243-22-019229#line-1","is_derivative":false,"issuer_cik":"0001750149","issuer_name":"Inhibikase Therapeutics, Inc.","issuer_ticker":"IKT","issuer_name_source":null,"issuer_url":"/issuer/0001750149","owner_cik":"0001827621","owner_name":"Werner Milton H.","owner_display_name":"Werner Milton H.","owner_url":"/insider/0001827621","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":5325433.0,"shares_owned_after_display":"5,325,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-23","scope":"insider"},{"id":4282848,"accession":"0001104659-21-141628","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-21-141628","line_url":"/filing/0001104659-21-141628","is_derivative":false,"issuer_cik":"0001750149","issuer_name":"Inhibikase Therapeutics, Inc.","issuer_ticker":"IKT","issuer_name_source":null,"issuer_url":"/issuer/0001750149","owner_cik":"0001827621","owner_name":"Werner Milton H.","owner_display_name":"Werner Milton H.","owner_url":"/insider/0001827621","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23589.0,"shares_display":"23,589","price_per_share":1.9737224977743864,"price_display":"1.97","price_state":"stated","total_value":46558.14,"total_display":"46,558.14","total_whole":"46,558","shares_owned_after":23589.0,"shares_owned_after_display":"23,589","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-17","filed_date":"2021-11-19","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001750149","name":"Inhibikase Therapeutics, Inc.","url":"/issuer/0001750149","role":"Director, Officer (President and CEO), Ten percent owner","n_filings":4,"first_seen":"2021-11-19","last_seen":"2022-08-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001827621","retrieved_at":"2026-08-24T23:35:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}